Revolutionising Surgical Care: Encare's €1.5M Investment Fuels Global Expansion
Leveraging Technology to Combat Post-Surgical Complications and Enhance Patient Recovery
Stockholm's health tech startup, Encare, recently secured a significant €1.5 million investment, marking a significant endorsement of its mission to revolutionise surgical care. This funding round, led by Sciety, a company dedicated to fostering the growth of life science companies in the Nordics, saw participation from both existing shareholders and a group of new investors eager to back Encare's innovative approach. Encare's software-as-a-service (SaaS) solution promises to transform healthcare providers' ability to implement best practices in surgical care, leading to improved patient outcomes. This new capital injection positions the company for continued growth and expansion into untapped international markets.
Every year, a staggering number of individuals undergo surgical procedures, entrusting their health to medical professionals. However, the post-operative phase presents a persistent challenge as about one in four patients continue to experience complications. Encare aims to tackle this issue with its software, claiming it can significantly reduce the risk of complications by a remarkable 50%. This reduction has profound implications, considering that complications can lead to severe consequences, including loss of life or a substantial strain on healthcare expenses.
Established in 2019, Encare has distinguished itself by focusing on optimising the entire patient care process, from initial diagnosis to comprehensive rehabilitation. By developing perioperative care protocols and adhering to the highest standards of research, education, and evidence-based practices, Encare has earned recognition as a pioneer in the field. In collaboration with leading clinical experts, the company has developed the ERAS Protocol—a revolutionary initiative to minimise post-operative complications and speed up the recovery process. This approach promises improved patient outcomes and cost reductions for healthcare providers and hospitals, raising the overall standard of care.
Encare's recent investment positions the company for sustained growth and sets the stage for expansion into untapped international markets. With their unwavering commitment to enhancing surgical care and their innovative SaaS solution at the forefront, Encare is set to make a lasting impact on the global healthcare landscape.
"Thanks to the continued support from our investors, we can continue our expansion and work towards our mission to positively impact the lives of millions of patients undergoing surgery worldwide. By supporting healthcare providers in implementing best practices in surgical care, Encare can contribute to reducing the number of preventable deaths and complications during surgery," says Rasmus Waller, CEO of Encare.